Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost.
about
Codon optimization of antigen coding sequences improves the immune potential of DNA vaccines against avian influenza virus H5N1 in mice and chickensProspects and progress of DNA vaccines for treating hepatitis B.An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial.Multigenic DNA vaccine induces protective cross-reactive T cell responses against heterologous influenza virus in nonhuman primates.A Review of DNA Vaccines Against Influenza
P2860
Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Phase I clinical evaluation of ...... ctivated vaccine (IIV3) boost.
@ast
Phase I clinical evaluation of ...... ctivated vaccine (IIV3) boost.
@en
type
label
Phase I clinical evaluation of ...... ctivated vaccine (IIV3) boost.
@ast
Phase I clinical evaluation of ...... ctivated vaccine (IIV3) boost.
@en
prefLabel
Phase I clinical evaluation of ...... ctivated vaccine (IIV3) boost.
@ast
Phase I clinical evaluation of ...... ctivated vaccine (IIV3) boost.
@en
P2093
P2860
P50
P1476
Phase I clinical evaluation of ...... ctivated vaccine (IIV3) boost.
@en
P2093
Alisha Kabadi
Brenda Larkin
Cynthia S Hendel
Donald M Poretz
Galina Yamshchikov
Ingelise Gordon
Lasonji Holman
Mary E Enama
Pamela Costner
Richard Koup
P2860
P304
P356
10.1016/J.CCT.2015.08.006
P407
P577
2015-08-11T00:00:00Z